Quanterix (NASDAQ: QTRX) net income
Quanterix reported a net loss of $107.2m for fiscal 2025; in fiscal 2024 it reported a net loss of $38.5m. Earnings per share were −$2.51.
Quanterix's best year of the last 9 was fiscal 2017. It reported a loss in 9 of those 9 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$107.2m | — | −77.1% | −$2.51 |
| 2024 | −$38.5m | — | −28.0% | −$1.00 |
| 2023 | −$28.4m | — | −23.2% | −$0.75 |
| 2022 | −$99.6m | — | −94.4% | −$2.69 |
| 2021 | −$55.5m | — | −50.2% | −$1.54 |
| 2020 | −$31.5m | — | −36.5% | −$1.07 |
| 2019 | −$40.8m | — | −71.9% | −$1.63 |
| 2018 | −$31.5m | — | −83.8% | — |
| 2017 | −$27.0m | — | −118.1% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Quanterix net income compared with its sector
By net income for its latest fiscal year, Quanterix ranks 344th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Quanterix, −77.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 342nd | Oruka Therapeutics | −$105.4m | — |
| 343rd | AURA Biosciences | −$106.2m | — |
| 344th | Quanterix | −$107.2m | −77.1% |
| 345th | NeoGenomics | −$108.0m | −14.9% |
| 346th | Taysha Gene Therapies | −$109.0m | −1,115.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Quanterix
- How much did Quanterix earn in fiscal 2025?
- Quanterix reported a net loss of $107.2m for fiscal 2025. In fiscal 2024 it reported a net loss of $38.5m.
- What are the earnings per share of Quanterix?
- They were −$2.51 in fiscal 2025, compared with −$1.00 in fiscal 2024.
- Where does Quanterix rank in its sector by net income?
- It ranks 344th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Quanterix come from?
- From the annual report (Form 10-K) that Quanterix files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Quanterix files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Quanterix: the Quanterix page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.